Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Sorrento Therapeutics Inc (SRNE)

Sorrento Therapeutics Inc (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is Watching Stocktwits - Fri Nov 8, 1:10AM CST

Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.

SRNE : 0.0008 (-33.33%)
TNXP : 0.6116 (+7.30%)
IBB : 132.73 (+1.16%)
JAGX : 0.9255 (+6.00%)
NVAX : 8.70 (+0.23%)
INO : 1.8400 (-0.27%)
GILD : 92.57 (+1.62%)
MRNA : 39.39 (-0.43%)
VXRT : 0.6196 (+2.70%)
IBIO : 2.48 (+2.48%)
XBI : 91.28 (+1.64%)
PFE : 26.36 (+2.29%)
Why Shares of Scilex Slumped This Week Motley Fool - Fri Apr 28, 2023

A stock sale and confusion regarding its parent company are factors dragging down the stock.

SRNE : 0.0008 (-33.33%)
SRNEQ : 0.0300 (+3.45%)
SCLX : 0.4475 (+1.64%)
Why Sorrento Therapeutics Stock Crashed Today Motley Fool - Wed Feb 22, 2023

Any euphoria after the biotech stock's big jump yesterday didn't last long.

SRNE : 0.0008 (-33.33%)
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case PR Newswire - Tue Feb 21, 2023

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SRNE : 0.0008 (-33.33%)
SCLX : 0.4475 (+1.64%)
Why Shares of Sorrento Therapeutics Are Up Today Motley Fool - Tue Feb 21, 2023

The company is walling off subsidiary Scilex from its bankruptcy proceedings.

SRNE : 0.0008 (-33.33%)
Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions PR Newswire - Thu Feb 16, 2023

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SRNE : 0.0008 (-33.33%)
SCLX : 0.4475 (+1.64%)
Why Sorrento Therapeutics Stock Is Crashing Today Motley Fool - Mon Feb 13, 2023

A bankruptcy filing is weighing on the drugmaker's shares today.

SRNE : 0.0008 (-33.33%)
Wall Street Thinks These 2 Penny Stocks Could Go Parabolic Motley Fool - Thu Feb 9, 2023

Wall Street is bullish on these two beaten-down healthcare stocks.

ATAI : 1.1900 (unch)
SRNE : 0.0008 (-33.33%)
MarketBeat: Week in Review 01/09-01/13 MarketBeat - Sat Jan 14, 2023

Markets are looking for direction in early trading before a holiday weekend. Here are some of the popular stories MarketBeat analysts were covering this week.

SQ : 89.65 (+2.29%)
SNAP : 11.40 (+0.88%)
SHC : 13.24 (-0.23%)
SRNE : 0.0008 (-33.33%)
SCLX : 0.4475 (+1.64%)
CWH : 21.31 (+5.03%)
M : 16.24 (+2.46%)
BABA : 82.28 (-2.41%)
WEN : 16.65 (+0.48%)
LMT : 489.02 (+1.95%)
BE : 24.12 (+5.42%)
AMZN : 224.92 (+0.73%)
Author
Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move MarketBeat - Thu Jan 12, 2023

Sorrento Therapeutics is on the move following preliminary results from its subsidiary Scilex. Scilex is making money with the company's 1st product to market

SRNE : 0.0008 (-33.33%)
SCLX : 0.4475 (+1.64%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot